Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
aging, aging paradox, ai, biotech, biotech hype, drugs, longevity, medicine, neuroethics, p, pharma-politics, synthetic biology